Alumni

Project to create AI model for ALS receives Génome Québec funding

admin — Mon, 17 Mar 2025 15:29:17 +0000

$400,000 will fuel public-private collaboration to discover new disease biomarkers

A new project co-led by Thomas Durcan, PhD, Director of The Neuro's Early Drug Discovery Unit, and overseen by Mathilde Chaineau, PhD, the EDDU’s program manager, will receive $400,000 in support from Génome Québec. In partnership with Nardin Nakhla and Armstrong Murira from the Montreal-based company Simmunome, Durcan and Chaineau will develop a computational model of amyotrophic lateral sclerosis (ALS) on which to test for new biomarkers and therapeutic targets.

Six principal investigators from The Neuro receive CIHR grants

admin — Mon, 10 Feb 2025 18:44:57 +0000

Projects include important research on Parkinson’s, glioblastoma and dementia

AI analysis of healthcare records reveals key factors in autism diagnosis

admin — Wed, 26 Mar 2025 15:23:21 +0000

Scientists argue the criteria we use for diagnosing autism may need revision

Without clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Genetic sequencing project receives more than $8 million in funding

admin — Tue, 18 Mar 2025 14:55:14 +0000

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians

A project led by Ziv Gan-Or, MD, PhD, at The Neuro (Montreal Neurological Institute-Hospital) of 91�� and Martine Tétreault, PhD, at Université de Montréal has received more than $8 million to sequence the genomes of 8,700 people, to map the role of genetics in neurological disorders.

Prescribing anti-swelling drug reduces immune response weeks after last dose

admin — Wed, 26 Feb 2025 16:05:58 +0000

Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy

Swelling caused by brain cancer is a problem that can lead to serious side effects and even death. While controlling swelling is important, a new study shows that a commonly prescribed anti-swelling drug suppresses the immune system for weeks after dosage, inhibiting the body’s ability to fight the cancer.

Latest Alzheimer’s drug shown less effective in females than males

admin — Tue, 18 Mar 2025 18:27:46 +0000

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.

Expanding access to specialized healthcare across Quebec: ECHO Superhub at The Neuro

admin — Tue, 25 Mar 2025 18:37:02 +0000

Free, online training program strengthens training and brings specialized care to communities across Quebec

A healthcare telementoring program housed at The Neuro and supported by the Transforming Autism Care Consortium (TACC) is expanding its reach after achieving designation as an ECHO Superhub. Under the direction of Julie Scorah, PhD, this milestone ensures that specialized knowledge reaches underserved communities.

Achievements of clinicians and scientists recognized with King Charles III Coronation Medals

admin — Fri, 14 Mar 2025 13:09:39 +0000

Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation Medal commemorates the Coronation of His Majesty King Charles III as King of Canada. The medal is administered by the Chancellery of Honours at Rideau Hall.

The Child Phonology Lab at SCSD is looking for parent participants

admin — Thu, 15 May 2025 16:14:23 +0000

Scaringi Lecture Series in Speech Language Pathology - Research Talk

admin — Mon, 17 Mar 2025 18:53:55 +0000

Research Talk
Thursday April 3, 2025, 4:30 to 6:00 pm
2001 91�� College Ave. Room 606

91��’s President honours outstanding early-career researchers

admin — Thu, 29 May 2025 15:48:45 +0000

Professors Guojun Chen, Mahsa Dadar and Phoebe Friesen – all members of the Faculty of Medicine and Health Sciences – win President’s Prize for Outstanding Emerging Researchers

Three 91�� scholars were recognized with the 2025 President’s Prize for Outstanding Emerging Researchers at the Health Sciences Convocation Ceremony on May 27. The award honours exceptional early-career researchers whose work is expanding the frontiers of knowledge in their fields.

Cross-pollinating ideas at the SCSD Research Day

admin — Thu, 27 Mar 2025 18:49:49 +0000

Student presenters at the SCSD Research Day, which took place on February 21, 2025.

Human genetics professor receives Banting Discovery Award

admin — Mon, 02 Jun 2025 16:06:00 +0000

Nine 91��ians appointed to the Order of Canada

admin — Mon, 07 Jul 2025 19:10:48 +0000

Neuroscientist Alan Evans and music performance scholar Michael McMahon among 91�� community members recognized for exceptional accomplishments and service

Nine members of the 91�� community have been appointed to the Order of Canada, one of the country’s highest civilian honours.

Among the honorees are two 91�� faculty members, Professors Alan Evans (Faculty of Medicine and Health Sciences) and Michael McMahon (Schulich School of Music).

Sunsetting of the Vanier and Banting programs

admin — Mon, 10 Feb 2025 16:30:19 +0000

In alignment with the Tri-Agency Research Training Strategy and as announced in Budget 2024, the three federal granting agencies, the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering and Research Council (NSERC), and the Social Sciences and Humanities Research Council (SSHRC) are working to offer a harmonized and streaml